Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model/Experiment 1

From BugSigDB


Needs review

Curated date: 2025/02/13

Curator: KateRasheed

Revision editor(s): KateRasheed, WikiWorks

Subjects

Location of subjects
Switzerland
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Cecum mucosa Caecum mucosa,Caecum mucosa of organ,Caecum mucous membrane,Caecum organ mucosa,Cecal mucosa,Cecum mucosa of organ,Cecum mucous membrane,Cecum organ mucosa,Intestinum crassum caecum mucosa,Intestinum crassum caecum mucosa of organ,Intestinum crassum caecum mucous membrane,Intestinum crassum caecum organ mucosa,Mucosa of caecum,Mucosa of cecum,Mucosa of intestinum crassum caecum,Mucosa of organ of caecum,Mucosa of organ of cecum,Mucosa of organ of intestinum crassum caecum,Mucous membrane of caecum,Mucous membrane of cecum,Mucous membrane of intestinum crassum caecum,Organ mucosa of caecum,Organ mucosa of cecum,Organ mucosa of intestinum crassum caecum,Cecum mucosa,cecum mucosa
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to transplant Response to transplant,response to transplant
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Untreated Mice- Fecal Microbiota Transplant (Mice-FMT)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Alzheimer's disease(AD) patient (AD-FMT)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This refers to an 80-year-old Alzheimer's disease(AD) patient; with no protection to AD, clinical diagnosis of dementia, brain amyloidosis, APOEε4 carrier genotype, female gender.
Group 1 sample size Number of subjects in the case (exposed) group
1

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
arcsine square-root
Statistical test
MaAsLin2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.02
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Needs review

Curated date: 2025/02/13

Curator: KateRasheed

Revision editor(s): KateRasheed, WikiWorks

Source: Fig. 3C

Description: Differential abundance of genera between the FMT recipient mice

Abundance in Group 1: decreased abundance in Alzheimer's disease(AD) patient (AD-FMT)

NCBI Quality ControlLinks
Rs-E47 termite groupRs-E47 termite group
UCG-010UCG-010
Rikenellaceae RC9 gut groupRikenellaceae RC9 gut group
Candidatus Gastranaerophilales
Eubacterium coprostanoligenes groupEubacterium coprostanoligenes group
Mucispirillum
Ligilactobacillus

Revision editor(s): KateRasheed, WikiWorks